AAAAAA
Results:
1-13
|
Results: 13
Authors:
GUERQUINKERN JL
COPPEY M
CARREZ D
BRUNET AC
NGUYEN CH
RIVALLE C
SLODZIAN G
CROISY A
Citation: Jl. Guerquinkern et al., COMPLEMENTARY ADVANTAGES OF FLUORESCENCE AND SIMS MICROSCOPIES IN THESTUDY OF CELLULAR-LOCALIZATION OF 2 NEW ANTITUMOR DRUGS, Microscopy research and technique, 36(4), 1997, pp. 287-295
Authors:
ROUTIER S
BERNIER JL
CATTEAU JP
COLSON P
HOUSSIER C
RIVALLE C
BISAGNI E
BAILLY C
Citation: S. Routier et al., SYNTHESIS, DNA-BINDING, AND CLEAVING PROPERTIES OF AN ELLIPTICINE-SALEN-CENTER-DOT-COPPER CONJUGATE, Bioconjugate chemistry, 8(6), 1997, pp. 789-792
Authors:
RIVALLE C
BISAGNI E
Citation: C. Rivalle et E. Bisagni, ETHYL(4-N-ACYLAMINOPYRIDIN-3-YL)GLYOXYLATE AND 5-AZAISATIN AS NEW SYNTHONS FOR A ROUTE TO VARIOUS NEW POLYHETEROCYCLES, Journal of heterocyclic chemistry, 34(2), 1997, pp. 441-444
Authors:
RENAULT E
FONTAINEAUPART MP
GARDESALBERT M
RIVALLE C
BISAGNI E
Citation: E. Renault et al., RADICAL CHEMISTRY OF THE ANTITUMOR DRUG PAZELLIPTINE (PZE) IN AQUEOUS-SOLUTION OR INTERCALATED IN POLY(DA)-POLY(DT), Journal de chimie physique et de physico-chimie biologique, 93(1), 1996, pp. 194-202
Authors:
JOLIVET C
RIVALLE C
BISAGNI E
Citation: C. Jolivet et al., SYNTHESIS OF PYRANO[2,3-H]QUINOLINES AS TRICYCLIC ACRONYCINE ANALOGS, Heterocycles, 43(5), 1996, pp. 995-1005
Authors:
JOLIVET C
RIVALLE C
CROISY A
BISAGNI E
Citation: C. Jolivet et al., SYNTHESIS AND BEHAVIOR OF FURO[2,3,4-K,L]ACRIDINES AND FURO[2,3,4-K,L]PYRANO[3,2-H]ACRIDINES, Heterocycles, 43(3), 1996, pp. 641-651
Authors:
FONTAINEAUPART MP
LAGUITTONPASQUIER H
PANSU R
BRIAN L
RENAULT E
MARDEN MC
RIVALLE C
BISAGNI E
Citation: Mp. Fontaineaupart et al., PROTON AND CHARGE-TRANSFER IN THE INTERCALATING ANTITUMOR DRUG PAZELLIPTINE, Perkin transactions. 2, (8), 1996, pp. 1767-1774
Authors:
JOLIVET C
RIVALLE C
BISAGNI E
Citation: C. Jolivet et al., REACTION OF NORACRONYCINE AND 1-HYDROXY-3-METHOXY-10-METHYLACRIDONE WITH ALKYL-LITHIUMS AND ARYL-LITHIUMS - FORMATION OF QUINONE METHIDES, Journal of the Chemical Society. Perkin transactions. I, (4), 1995, pp. 511-515
Authors:
JOLIVET C
RIVALLE C
HUEL C
BISAGNI E
Citation: C. Jolivet et al., REACTION OF ORTHO-LITHIATED PROTECTED ANILINES WITH O-HYDROXYCARBONYLCOMPOUNDS - FORMATION OF QUINO-ACRIDINES AND PYRANOQUINO-ACRIDINES, Journal of the Chemical Society. Perkin transactions. I, (18), 1995, pp. 2333-2337
Authors:
RIVALLE C
BISAGNI E
Citation: C. Rivalle et E. Bisagni, SYNTHESIS OF 9-METHOXYELLIPTICINE N-OXIDE AND ITS TRANSFORMATION INTO1-FUNCTIONALIZED ELLIPTICINE DERIVATIVES, Heterocycles, 38(2), 1994, pp. 391-397
Authors:
BAILLY C
MICHAUX C
COLSON P
HOUSSIER C
SUN JS
GARESTIER T
HELENE C
HENICHART JP
RIVALLE C
BISAGNI E
WARING MJ
Citation: C. Bailly et al., REACTION OF A BISCATIONIC DISTAMYCIN-ELLIPTICINE HYBRID LIGAND WITH DNA - MODE AND SEQUENCE SPECIFICITY OF BINDING, Biochemistry, 33(51), 1994, pp. 15348-15364
Authors:
FONTAINEAUPART MP
FREJACQUES M
RENAULT E
FERRADINI C
GARDESALBERT M
HICKEL B
RIVALLE C
BISAGNI E
Citation: Mp. Fontaineaupart et al., 2-PHOTON IONIZATION OF THE ANTITUMOR DRUG PAZELLIPTINE (BD40) BY 355-NM LASER PHOTOLYSIS, Journal of photochemistry and photobiology.B, Biology, 21(2-3), 1993, pp. 203-209
Authors:
BAILLY C
LECLERE V
POMMERY N
COLSON P
HOUSSIER C
RIVALLE C
BISAGNI E
HENICHART JP
Citation: C. Bailly et al., BINDING TO DNA, CELLULAR UPTAKE AND BIOLOGICAL-ACTIVITY OF A DISTAMYCIN ELLIPTICINE HYBRID MOLECULE, Anti-cancer drug design, 8(2), 1993, pp. 145-164
Risultati:
1-13
|